Purdue Pharma Reaches $8B Opioid Deal With Justice Department Over Oxycontin Sales
Critics say the settlement doesn't hold company executives or members of the Sackler family accountable for their aggressive marketing of Oxycontin which helped fuel the nation's opioid epidemic.
Updated at 12:14 p.m. ET
The Justice Department announced on Wednesday a global settlement of civil and criminal investigations into Purdue Pharma's aggressive marketing of opioid medications, including Oxycontin.
Federal officials have long maintained Purdue's actions helped fuel a prescription opioid epidemic that has killed more than 232,000 Americans, according to the Centers for Disease Control and Prevention.
But the deal unveiled Wednesday morning, which includes three felony guilty pleas, won't result in company
